State Medicaid programs already are allowed to offer GLP-1 drugs for weight loss, but only 13 state programs currently do so. Meanwhile, Medicare currently covers GLP-1 drugs for people with a ...

President Donald Trump set a deadline of Sept. 19 for pharmaceutical companies to commit to complying with his demands of ...

Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach ...

A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.

Medicare and Medicaid could expand coverage of GLP-1 drugs, such as Ozempic and Wegovy, and pay for patients’ use of the ...

More than a dozen Democratic attorneys general on Friday announced a lawsuit challenging recent moves by President Trump’s administration to severely restrict access to gender-affirming health ...

The Trump administration is considering a shift in health care coverage, allowing Medicare and Medicaid to cover GLP-1 weight loss drugs.

Trump appeared unable to keep his eyes open during the conference announcing they were launching a new program that will ...

Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...

Leadership at the Centers for Medicare and Medicaid Services is working with states to develop plans to use the $50 billion ...

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...